Epidemiology of acute otitis media among young children: A multiple database study in Taiwan  by Ting, Pei-Ju et al.
Journal of Microbiology, Immunology and Infection (2012) 45, 453e458Available online at www.sciencedirect.com
journal homepage: www.e- jmii .comORIGINAL ARTICLE
Epidemiology of acute otitis media among young
children: A multiple database study in TaiwanPei-Ju Ting a,b, Ching-Heng Lin c, Fang-Liang Huang a, Ming-Chih Lin a,
Kao-Pin Hwang d, Yhu-Chering Huang e, Cheng-Hsun Chiu e,
Tzou-Yien Lin e, Po-Yen Chen a,*aDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan
bDepartment of Pediatrics, Lin Shin Hospital, Taichung, Taiwan
cDepartment of Research, Taichung Veterans General Hospital, Taichung, Taiwan
dDepartment of Pediatrics, China Medical University Hospital, Taichung, Taiwan
eDepartment of Pediatrics, Children’s Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Received 30 April 2011; received in revised form 1 August 2011; accepted 31 August 2011KEYWORDS
Children;
Epidemiology;
Otitis media* Corresponding author. Department
407, Taiwan, ROC.
E-mail addresses: pychen@vghtc.g
1684-1182/$36 Copyright ª 2012, Taiw
http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose: Acute otitis media (AOM) is a common complication of upper respiratory
tract infection (URTI) among children. The purpose of this study was to evaluate the epidemi-
ology of AOM among young children in Taiwan, including the age incidence and seasonality by
combining multiple databases.
Methods: Two country-based questionnaire survey studies had been conducted to evaluate the
experience of otitis media (OM) among young children: one in 2007 and the other between
2005 and 2010. The number of OM cases (5% of population younger than 7 years) in 2005 and
annual visiting rates for URTI from 2005 to 2010 obtained from the National Health Insurance
Research Database of Taiwan were collected and comprised the third database. The fourth
database comprised ambulatory visits of children with OM to a medical center in central
Taiwan between 2005 and 2010.
Results: Data from a total of 1099 questionnaires were entered into Database I in 2007, and
data from 9705 questionnaires between 2005 and 2010 comprised Database II. There were
86,702 children (younger than 7 years, representing 5% of the whole population for this age
group) retrieved from Database III in 2007, and 5,904 cases of OM in children between 2005
and 2010 in a hospital. In Database I, 7.46% children experienced at least one episode of
AOM compared with 9.21% in Database II for children aged 5 years and younger. In Database
III, 13.2% children younger than 7 years had AOM in 2005. The peak season of AOM among chil-
dren was from March to May (Databases III and IV).of Pediatrics, Taichung Veterans General Hospital, No. 160, Section 3, Chung-Kang Road, Taichung
ov.tw, pychen6368@yahoo.com.tw (P.-Y. Chen).
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454 P.-J. Ting et al.Conclusion: AOM was thought to be a very common disease among children; however, this
comparative analysis showed that the overall prevalence of AOM among children younger than
5 years was only 20%, much lower than in other countries. AOM was more prevalent during the
spring season, and still was similarly common after age 2 years.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
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Acute otitis media (AOM) is a common complication usually
following upper respiratory tract infection (URTI) during
early childhood. It is also the most common reason for
prescribing antibiotics for children.1,2 It was estimated that
the expenditure on otitis media (OM) per year in the United
States was 2.8 billion US dollars, with the mean cost per
child in 2006 being 350 US dollars.3 There is little infor-
mation about the true picture of OM in Taiwan. OM may
further lead to more complications if left untreated, such
as mastoiditis, hearing loss, sepsis, meningitis, brain
abscess, and subdural empyema.4e6 Teele et al conducted
a prospective, cohort study in 1989 and estimated that 62%
of children had a least of one episode of AOM by age 1 year,
and up to 83% by age 3 years.7 Recent studies from several
other countries, however, have shown much lower inci-
dence of AOM.8 Wang et al, using the National Health
Insurance (NHI) claims database of Taiwan, estimated that
the age-specific annual incidence of OM was 71.7 per 1000
children aged <2 years, and 158.8 per 1000 3- to 5-year-
olds, and 4.0 per 1000 children aged 6 to 12 years.9 These
data show a quite different incidence of OM among children
in Taiwan as compared with other countries.
A few studies have tried to evaluate the prevalence and
incidence of AOM in Taiwan. One study surveyed the inci-
dence OM in kindergartens from May to July on 2001,10
while another focused on the incidence at any age and
the management of different medical specialties in giving
a diagnosis of OM.9 The purpose of this study was to eval-
uate the prevalence and incidence of OM, and the epide-
miological pattern of OM among young children, and to
compare the differences of the epidemiology of OM with
previous survey studies in Taiwan.Methods
Database I
A questionnaire-based survey was conducted in a pediatric
outpatient setting in five medical centers in Taiwan
(National Taiwan University Hospital, Taipei; Chang Gung
Memorial Hospital, Taoyuan; Taichung Veterans General
Hospital, Taichung; Chang Gung Memorial Hospital, Kaoh-
siung; and Tzu Chi General Hospital, Hualien) from January
to June 2007. The patients’ parents were requested to
answer a predesigned questionnaire after the purpose of
the study was explained to them and written informed
consent had been obtained. The case numbers enrolled
from each region were predetermined by assessing thepercentage of children of each region, and a total of 1200
children and questionnaires were required so that the total
number comprised 0.1% of the pediatric population younger
than 5 years in 2006 (approximately 1,290,000 persons,
according to the data of the Ministry of the Interior,
Taiwan). They were divided into 4 groups, according to the
place of residence (40% from north Taiwan, 30% from
central Taiwan, 25% from south Taiwan, and 5% from east
Taiwan).
Database II
From July 2005 to December 2010, young children, aged
between 2 months and 5 years, who visited a well-child or
general pediatric outpatient clinic at one of three medical
centers in different regions in Taiwan (Chang Gung Memo-
rial Hospital, Taoyuan; Taichung Veterans General Hospital,
Taichung; and Chang Gung Memorial Hospital, Kaohsiung)
were invited to participate in this study. Subjects were
stratified equally into seven age groups in each hospital: >6
months, 6e12 months, 12e18 months, 18e24 months, 2e3
years, 3e4 years, and 4e5 years. Children with underlying
medical conditions, including chronic renal failure, dialysis,
nephritic syndrome, indwelling devices, thalassemia major,
chronic cardiovascular diseases, chronic lung disease, liver
cirrhosis, diabetes mellitus, congenital immunodeficiency,
human immunodeficiency virus infection, asplenia, and
malignancy, or receiving immunosuppressant agents were
excluded.
In Database I, the patients’ basic demographic data
were collected and parents were asked whether their child
had any history of AOM and, if so, how frequent the
episodes were. In Database II, which covered 5.5 years,
caregivers were asked whether the patient had any history
of AOM, and were whether nasopharyngeal bacterial
carriage survey studies had been performed.
Database III
We used a representative database extracted randomly
from the entire NHI Research Database (NHIRD) in Taiwan
was used as the third database in this study. The database
included approximately 5% of Taiwan’s young children
population aged up to 7 years. Claims data were retrieved
from patients aged <7 years with a diagnosis of AOM or OM
[International Classification of Diseases, Ninth Revision,
Clinical Modification codes (ICD-9-CM): 381.00e381.06,
381.4, 382.00e382.02, 382.4, 382.9] from January to
December 2005. Each person in the database was deemed
to be with or without OM in 2005, even for patients who
may have made multiple visits for OM. Statistical data from
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other acute URTIs (ICD-9-CM: 460e462,465) obtained from
the Department of Health were also used for comparison.
Database IV
This was a retrospective cross-sectional descriptive study of
children aged <7 years at ambulatory visits to Taichung
Veterans General Hospital from January 2005 to December
2010 with a primary or secondary diagnosis of AOM or OM
(ICD-9-CM: 381.00e381.06, 381.4, 382.00e382.02, 382.4,
382.9).
Statistical analysis
All statistical analyses in this study were performed using
the SPSS version 11 (SPSS Inc., Chicago, IL, USA). Differ-
ences between groups were analyzed by Chi-square test. A
p value of <0.05 was considered to be significant.
Results
In Database I, a total of 1099 questionnaires for children
younger than 5 years w completed from January to June
2007. The demographic data and experience of OM are
summarized in Table 1. Forty-four boys (7.91%) and 38 girls
(7.25%) had experience of AOM. Among the 1099 children
younger than 5 years, 82 (7.46%) had experienced at least
one episode of AOM. By age 5 years, 20.17% of the children
had suffered at least one episode of AOM. The prevalence
of AOM differed according to region, with 10.16% of the
studied children in north Taiwan, 5.41% in central Taiwan,
4.31% in south Taiwan, and 13.33% in east Taiwan. There
was a higher prevalence of AOM among children in east
Taiwan compared with rates in other regions. AmongTable 1 Demographic data of children with acute otitis media (
Characteristic Database I
No. of
patients
AOM-experie
No. of patie
Sex
Boys 556 44 (7.91%)
Girls 524 38 (7.25%)
Age (years)
<0.5 105 0 (0%)
0.5e1 147 5 (3.40%)
1e2 345 17 (4.93%)
2e3 237 22 (9.28%)
3e4 146 14 (9.59%)
4e5 119 24 (20.17%)
Region
North Taiwan 433 44 (10.16%)
Central Taiwan 351 19 (5.41%)
South Taiwan 255 11 (4.31%)
East Taiwan 60 8 (13.33%)
Total 1099 82 (7.46%)children who had experienced AOM, 55 (67%) experienced
only one episode of AOM, while 14 (17%) had two episodes,
and 13 children (16%) had more than two episodes.
In Database II, a total of 9705 questionnaires were
completed from July 2005 to December 2010 for children
aged between 2 months and 5 years. The demographic data
and experience of OM are summarized in Table 1. There
were 516 boys (9.78%) and 378 girls (8.53%) with experience
of AOM. There were 894 children (9.21%) who had experi-
enced at least one episode of AOM. By the age of 5 years,
20.37% of these children had experienced AOM. The prev-
alence of AOM also was different among regions: 10.24% in
north Taiwan, 6.36% in central Taiwan, and 10.91% in south
Taiwan.
In Database III, there were 86,702 children, which
included 45,420 boys and 41,282 girls aged younger than 7
years in 2005. A total of 6326 boys (15.2%) and 5157 girls
(13.5%) had OM in 2005 (Table 2). Boys had a significantly
greater prevalence of OM (p < 0.001). Three percent of
babies had suffered from OM by the age 1 year. Children
aged between 1 and 5 years experienced approximate
prevalence of OM (14.9e17.8%) at each age from 1 through
5 years old (Table 2). The peak season of AOM was observed
during March to May (Fig. 1).
In Database IV, there were 5904 children, and 42.6% of
them were girls. Children aged between 4 and 5 years had
more ambulatory visits for AOM (Table 2). The peak season
of AOM was in spring, which was the same as that observed
in Database III (Fig. 1).
Discussion
AOM is a common respiratory disease among young chil-
dren, and requires the initiation of antimicrobial therapy.
Previous studies have shown a high prevalence of AOM
among young children. The 7-valent pneumococcalAOM) in 2007 (Database I) and from 2005 to 2010 (Database II)
Database II
nce No. of
patients
AOM-experience
nts (%) No. of patients (%)
5276 516 (9.78%)
4429 378 (8.53%)
1371 8 (0.58%)
1418 31 (2.19%)
2763 220 (7.96%)
1415 159 (11.24%)
1378 199 (14.44%)
1360 277 (20.37%)
3281 336 (10.24%)
3144 200 (6.36%)
3280 358 (10.91%)
d d
9705 894 (9.21%)
Table 2 Demographic data of children with acute otitis
media (OM) in 2005 in National Health Insurance Research
Database (database III) and from 2005 to 2010 in Veterans
General Hospital, Taichung (database IV)
Characteristic Database III Database IV
No. of
subjects
No. of
patients
with OM (%)
No. of
patients
with OM
Sex
Boys 45,420 6326 (13.9%) 3352
Girls 41,282 5157 (12.5%) 2552
Age (years)
<0.5 8417 251 (3.0%) 76
0.5e1 9357 1522 (16.3%) 731
1e2 9898 1605 (16.2%) 864
2e3
3e4 10,529 1570 (14.9%) 734
4e5 11,143 1987 (17.8%) 1028
5e6 13,215 2078 (15.7%) 1157
6e7 12,423 1482 (11.9%) 806
7e8 11,720 988 (8.4%) 508
Total 86,702 11,483 (13.2%) 5904
456 P.-J. Ting et al.conjugate vaccine (PCV7) has demonstrated some efficacy
in preventing OM.11,12 However, the incidence of OM
remains high. In 2008/2009 (8 years since PCV-7 was
introduced in Canada), it was still estimated that 50% of
Canadian children had at least one OM episode by the age
of 3 years.13
To elucidate the true incidence and prevalence of OM in
Taiwan, we combined and compared multiple databases.
The potential confounding factors of OM, including age,
gender, seasonality, multiple outpatient visits, and
hospital-based and nonhospital-based pediatric pop-
ulations, were evaluated. This study showed that the inci-
dence of OM among young children in Taiwan was much
lower than those in Europe and America (Table 2).7,13e15
The two questionnaire studies revealed that only 20% of
children suffered OM by the age of 5 years. A cross-
sectional study in Taiwan in 2001 showed that the preva-
lence of OM among 3013 children (aged 3e6 years) amongFigure 1. Monthly distribution of acute otitis media among
children in 2005 by National Health Insurance Research Data-
base (NHIRD) and in Veterans General Hospital, Taichung
(VGHTC) from 2005 to 2010.19 kindergartens in Kaohsiung was 9.82%.10 However, this
cross-sectional survey, due to the nature of the study
design, only revealed the incidence at that time. Many
studies have demonstrated that the incidence of OM among
children peaked before the age of 2 years.7,15e17 The easy
accessibility of medical care in Taiwan, due to the NHI
program, can wrongly indicate a high incidence of AOM due
to multiple clinical visits. The NHIRD data revealed that
children aged 1 to 7 years experienced a similar rate of OM
among each age group (Table 2). Another study in Taiwan
demonstrated that a peak age incidence of AOM among
children was 3 to 5 years.9 The two questionnaire studies
showed that most of children in Taiwan had their first AOM
episode after infancy (Fig. 2). However, it did demonstrate
the peak age of AOM was those aged 1 to 2 years among
children in Taiwan, and was compatible with the other
studies.
Invasive pneumococcal disease (IPD) was enrolled into
the National Notifiable Disease Surveillance System in 2008,
and this surveillance and the study of Hsieh et al showed
the peak age of IPD among children were those aged 2 to 4
years.18 The peak incidence of IPD and OM in Taiwan was
among children aged between 2 and 5 years old, and it was
quite different from that in other countries. Chiou (1998)
collected 2905 nasopharyngeal (NP) swabs from children
attending day-care centers, kindergartens, and outpatient
clinics in south Taiwan, and showed a 21% NP carriage rate
of Streptococcus pneumoniae.19 An island-wide prospective
surveillance study during 2005 to 201020 demonstrated
a 12.8% NP carriage rates of S. pneumoniae among children
younger than 2 years old, compared with a higher NP
carriage of 19% among children aged 2 to 5 years old.20
Some studies have demonstrated a positive relationship
between the bacteriology of NP carriage, AOM and the
crowdedness of children, whether in the home or at an out-
of-home daycare unit.20e24 The decreasing birth rate,
reduced number of siblings and delayed babysitter atten-
dance were part of the reasonable explanation of the low
rate of NP carriage S. pneumoniae in Taiwan.
AOM, sinusitis, and pneumonia were three of the most
common complications following respiratory tract virus
diseases (common cold).17,23 Comparing the annual visitingFigure 2. Accumulative experience of otitis media (OM)
among children in 2007 (Database I) and from 2005 to 2010
(Database II).
Figure 3. Annual outpatient clinic visiting rates due to acute
upper respiratory tract infection (URTI) and the experience of
otitis media (OM) among young children (Database II) from 2005
to 2009. NHI Z National Health Insurance.
Epidemiology of AOM among children in Taiwan 457rates of URTI from the NHI database25 with the annual
proportions of OM-positive patients in Database II, we found
a similar age-peak trend (Fig. 3). The seasonal incidence
of AOM was compared from databases III (NHIRD) and IV
(TCVGH), as shown in Fig. 1, and demonstrated the higher
incidence in spring. This finding was also compatible with
the peak season of pneumococcal pneumonia and empyema
in Taiwan.26
There were significant differences in the proportions of
OM-experience children between different regions from
these two questionnaires, especially in south Taiwan. This
could be due to warmer weather and fewer URTI episodes
in the southern part of Taiwan. Other possible reasons for
these differences include a relative small sample size and
potential recall bias.
Many studies have shown that the risk of getting AOM is
higher in boys than girls,7,9,13,14,27 while others contradict
this.28,29 This study showed a higher incidence of AOM in boys
than girls, which is compatible with previous studies in
Taiwan.9,10 The core pathogens of AOMwere S. pneumoniae,
Haemophilus influenzae and Moraxella catarrhalis.23,30,31
The persistently high percentage of drug resistance of
these bacteria is a challenge for clinical management in
Taiwan, due to inadequate antibiotics, suboptimal dose,
long term exposure to antibiotics and drug concentration in
the middle ear.32 The PCV-7 vaccine has proved the good
efficacy in preventing IPD (meningitis, bacteremia, pneu-
monia etc.) in the United States.33 However, it showed only
limited efficacy on AOM (6e7%).11,34 The relatively low
efficacy of PCV7 is partly due to the presence of nonvaccine
S. pneumoniae serotypes and nontypable H. influenzae of
AOM.35e37 Newly licensed pneumococcal conjugate vaccines
(PCV-10 and PCV-13) have proved to be effective in pre-
venting AOM in some countries38e40 and the domestic
epidemiology is an essential factor for estimating the cost-
effectiveness of these vaccines in Taiwan.
One limitation of this study was related to the
questionnaire-based assessment of AOM episodes. Some of
the questionnaire respondents were not the principle
caregivers and might therefore have forgotten episodes of
AOM. Some respondents may not have understood the
questionnaire. In addition, the questionnaire-based data-
bases and data from VGHTC were extracted from hospital-
based outpatient clinics, which may not adequately reflectthe true prevalence among all children. The sample sizes in
these three databases may not be sufficiently large to avoid
bias. Another limitation was that some data were obtained
from the NHI database. Although this is a useful data source
for estimating epidemiological characteristics of AOM, the
accuracy of diagnostic coding by physicians can affect the
validity of data. Also, multiple visits may amplify the effect
of season.
In conclusion, AOM was believed to be a very common
disease among children; however, this comparative analysis
showed that the overall prevalence of AOM among
Taiwanese children younger than 5 years was only 20%,
much lower than other countries. AOM was more prevalent
during spring, and still was similarly common after the age
of 2 years.
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